Christopher M. Fashek's most recent trade in ENvue Medical Inc. was a trade of 50,000 Option to Purchase Common Stock done . Disclosure was reported to the exchange on Dec. 30, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ENvue Medical Inc | Christopher M. Fashek | Director | 30 Dec 2024 | 50,000 | 50,000 | - | - | Option to Purchase Common Stock | ||
| ENvue Medical Inc | M. Christopher Fashek | Director | 15 Nov 2023 | 14,000 | 14,000 | - | - | Option to Purchase Common Stock | ||
| ENvue Medical Inc | M. Fashek Christopher | Director | 15 Nov 2023 | 6,000 | 0 | - | - | Options to Purchase Common Stock | ||
| ENvue Medical Inc | M. Fashek Christopher | Director | 15 Nov 2023 | 4,000 | 0 | - | - | Options to Purchase Common Stock | ||
| ENvue Medical Inc | Fashek M. Christopher | Director | 15 Nov 2023 | 2,500 | 0 | - | - | Options to Purchase Common Stock | ||
| ENvue Medical Inc | Fashek M. Christopher | Director | 15 Nov 2023 | 2,100 | 0 | - | - | Options to Purchase Common Stock | ||
| ENvue Medical Inc | M. Christopher Fashek | Director | 15 Nov 2023 | 1,125 | 0 | - | - | Options to Purchase Common Stock | ||
| ENvue Medical Inc | Christopher M. Fashek | Director | 15 Jun 2022 | 40,000 | 75,000 (1%) | 1% | 0.6 | 23,828 | Common Stock |